cGxP.wire https://validator.w3.org/feed/docs/rss2.html DarioHealth Wins Fifth Fortune 50 Employer Contract Camurus NDA Resubmission for CAM2029 Accepted by FDA CU Anschutz Study Raises GLP-1 Compounding Concerns IDEAYA Showcases Darovasertib Data at ESMO 2026 4DMT Reports Positive 2-Year PRISM Phase 2b Data for 4D-150 BRIJ Medical Launches BRIJ-SEAL Advanced Wound Sealant Compass to Present Tovecimig Data at ESMO 2026 CoRegen Wins FDA IND Clearance for CRG-150 Allergan Aesthetics Wins EU Approval for Boey Neurotoxin Ananda Pharma Doses First Patient in Phase 2 CIPN Trial Telix Completes Phase 3 Enrollment for Illuccix in Japan Medifast Launches Trilivy Metabolic Health System FarmaMondo Partners with Cordex to Expand Zemcelpro Inflammasome Reports Positive Phase 2 K8 Results Dimerix Secures Funding to Advance DMX-200 Phase 3 Trial Agenus Showcases BOT+BAL Data Across Three ESMO 2026 Studies Xencor Shares Kidney Cancer Trial Results at ESMO Aqemia Broadens AI Drug Discovery Research with Sanofi FDA Grants EUA for Ivermectin to Prevent Horse Screwworm HERVolution Reports HERV-K Findings in Obesity Research UF Health Lung Transplant Program Earns Top Patient Outcomes Kalohexis Shares 710GO Data Supporting Durable Weight Loss Incyte Showcases Oncology Pipeline at ESMO Congress 2026 Dana-Farber Identifies CDK8 as Promising Target for Childhood Cancer Bambusa Reports Promising BBT002 Data for COPD Therapy Primrose Bio Earns $2M NIH Award for RNA Therapeutics PainTEQ Unveils New SI Joint Clinical Evidence at ASPN SpinaFX Earns CE Mark for Triojection Spine System Zentalis to Present Azenosertib Data at ESMO 2026 Veradermics Presents VDPHL01 Data at AAD 2026 Aptar Pharma Launches Injectable Drug Development Framework Amneal Wins FDA Approval for Expanded Iohexol Portfolio Evaxion Highlights Phase 2 EVX-01 Melanoma Results SS Innovations Highlights Surgical Robotics at SRS 2026 Galmed Accelerates Heart Failure Innovation with Aramchol GRAIL Teams with Priority Health to Expand Galleri Vanda Gains EMA Orphan Status for Imsidolimab in GPP Boehringer Ingelheim Wins EU Approval for JASCAYD Merck Wins FDA Approval for Oral PCSK9 Drug LIPFENDRA Clearmind Reports Positive Intranasal MEAI Results Lilly Acquires AtaiBeckley to Advance Depression Therapies Eurofins Viracor Expands Cytokine Testing Portfolio Mission Sells MTX652 to Dimerix in $292M Deal GSK Completes Nuvalent Acquisition to Expand Lung Cancer Moderna Doses First Patient in mRNA-4200 Cancer Trial Takeda Reports Strong Phase 3 Zasocitinib Results Arch Biopartners Accelerates IL-32 Chronic Kidney Disease Drug Program InnoCare Reports Positive Phase II Soficitinib Results Raidium Expands AI Radiology Platform to U.S. Cancer Centers Trellis Raises $9M to Advance Calpurbatug Phase 2 Trial